Open3.380 | Close3.180 |
Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
Open3.380 | Close3.180 |
Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.020 | 0.050 | 0.0300 | ||||
REV | 115.100M | 117.316M | 2.216M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-11 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Lowers | 5.00 | 3.00 |
2023-08-10 | BTIG | Ryan Zimmerman | Maintains | BuyBuy | Lowers | 10.00 | 4.00 |
2023-06-15 | Morgan Stanley | Drew Ranieri | Initiates Coverage On | Equal-Weight | Announces | - | 5.00 |
2023-05-24 | BTIG | Ryan Zimmerman | Upgrades | NeutralBuy | Announces | - | 10.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ORGO | Organogenesis Hldgs | -5.01% | 422.8M |
RNA | Avidity Biosciences | -3.96% | 466.8M |
FDMT | 4D Molecular Therapeutics | 0.71% | 535.3M |
CDNA | CareDx | -0.57% | 379.2M |
ANAB | AnaptysBio | -0.22% | 476.8M |
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Other companies in Organogenesis Hldgs’s space includes: Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), CareDx (NASDAQ:CDNA), AnaptysBio (NASDAQ:ANAB) and Agenus (NASDAQ:AGEN).
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Morgan Stanley on Friday, August 11, 2023. The analyst firm set a price target for 3.00 expecting ORGO to fall to within 12 months (a possible -6.83% downside). 5 analyst firms have reported ratings in the last year.
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $3.22 last updated September 29, 2023 at 9:08 PM UTC.
There is no dividend information for Organogenesis Hldgs.
Organogenesis Hldgs’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Organogenesis Hldgs.
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
Open3.380 | Close3.180 |
Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.020 | 0.050 | 0.0300 | ||||
REV | 115.100M | 117.316M | 2.216M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-11 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Lowers | 5.00 | 3.00 |
2023-08-10 | BTIG | Ryan Zimmerman | Maintains | BuyBuy | Lowers | 10.00 | 4.00 |
2023-06-15 | Morgan Stanley | Drew Ranieri | Initiates Coverage On | Equal-Weight | Announces | - | 5.00 |
2023-05-24 | BTIG | Ryan Zimmerman | Upgrades | NeutralBuy | Announces | - | 10.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ORGO | Organogenesis Hldgs | -5.01% | 422.8M |
RNA | Avidity Biosciences | -3.96% | 466.8M |
FDMT | 4D Molecular Therapeutics | 0.71% | 535.3M |
CDNA | CareDx | -0.57% | 379.2M |
ANAB | AnaptysBio | -0.22% | 476.8M |
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Other companies in Organogenesis Hldgs’s space includes: Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), CareDx (NASDAQ:CDNA), AnaptysBio (NASDAQ:ANAB) and Agenus (NASDAQ:AGEN).
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Morgan Stanley on Friday, August 11, 2023. The analyst firm set a price target for 3.00 expecting ORGO to fall to within 12 months (a possible -6.83% downside). 5 analyst firms have reported ratings in the last year.
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $3.22 last updated September 29, 2023 at 9:08 PM UTC.
There is no dividend information for Organogenesis Hldgs.
Organogenesis Hldgs’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Organogenesis Hldgs.
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
Open3.380 | Close3.180 |
Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.020 | 0.050 | 0.0300 | ||||
REV | 115.100M | 117.316M | 2.216M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-11 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Lowers | 5.00 | 3.00 |
2023-08-10 | BTIG | Ryan Zimmerman | Maintains | BuyBuy | Lowers | 10.00 | 4.00 |
2023-06-15 | Morgan Stanley | Drew Ranieri | Initiates Coverage On | Equal-Weight | Announces | - | 5.00 |
2023-05-24 | BTIG | Ryan Zimmerman | Upgrades | NeutralBuy | Announces | - | 10.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ORGO | Organogenesis Hldgs | -5.01% | 422.8M |
RNA | Avidity Biosciences | -3.96% | 466.8M |
FDMT | 4D Molecular Therapeutics | 0.71% | 535.3M |
CDNA | CareDx | -0.57% | 379.2M |
ANAB | AnaptysBio | -0.22% | 476.8M |
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Other companies in Organogenesis Hldgs’s space includes: Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), CareDx (NASDAQ:CDNA), AnaptysBio (NASDAQ:ANAB) and Agenus (NASDAQ:AGEN).
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Morgan Stanley on Friday, August 11, 2023. The analyst firm set a price target for 3.00 expecting ORGO to fall to within 12 months (a possible -6.83% downside). 5 analyst firms have reported ratings in the last year.
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $3.22 last updated September 29, 2023 at 9:08 PM UTC.
There is no dividend information for Organogenesis Hldgs.
Organogenesis Hldgs’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Organogenesis Hldgs.
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
Open3.380 | Close3.180 |
Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.020 | 0.050 | 0.0300 | ||||
REV | 115.100M | 117.316M | 2.216M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-11 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Lowers | 5.00 | 3.00 |
2023-08-10 | BTIG | Ryan Zimmerman | Maintains | BuyBuy | Lowers | 10.00 | 4.00 |
2023-06-15 | Morgan Stanley | Drew Ranieri | Initiates Coverage On | Equal-Weight | Announces | - | 5.00 |
2023-05-24 | BTIG | Ryan Zimmerman | Upgrades | NeutralBuy | Announces | - | 10.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ORGO | Organogenesis Hldgs | -5.01% | 422.8M |
RNA | Avidity Biosciences | -3.96% | 466.8M |
FDMT | 4D Molecular Therapeutics | 0.71% | 535.3M |
CDNA | CareDx | -0.57% | 379.2M |
ANAB | AnaptysBio | -0.22% | 476.8M |
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Other companies in Organogenesis Hldgs’s space includes: Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), CareDx (NASDAQ:CDNA), AnaptysBio (NASDAQ:ANAB) and Agenus (NASDAQ:AGEN).
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Morgan Stanley on Friday, August 11, 2023. The analyst firm set a price target for 3.00 expecting ORGO to fall to within 12 months (a possible -6.83% downside). 5 analyst firms have reported ratings in the last year.
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $3.22 last updated September 29, 2023 at 9:08 PM UTC.
There is no dividend information for Organogenesis Hldgs.
Organogenesis Hldgs’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Organogenesis Hldgs.
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
Open3.380 | Close3.180 |
Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.020 | 0.050 | 0.0300 | ||||
REV | 115.100M | 117.316M | 2.216M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-11 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Lowers | 5.00 | 3.00 |
2023-08-10 | BTIG | Ryan Zimmerman | Maintains | BuyBuy | Lowers | 10.00 | 4.00 |
2023-06-15 | Morgan Stanley | Drew Ranieri | Initiates Coverage On | Equal-Weight | Announces | - | 5.00 |
2023-05-24 | BTIG | Ryan Zimmerman | Upgrades | NeutralBuy | Announces | - | 10.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ORGO | Organogenesis Hldgs | -5.01% | 422.8M |
RNA | Avidity Biosciences | -3.96% | 466.8M |
FDMT | 4D Molecular Therapeutics | 0.71% | 535.3M |
CDNA | CareDx | -0.57% | 379.2M |
ANAB | AnaptysBio | -0.22% | 476.8M |
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Other companies in Organogenesis Hldgs’s space includes: Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), CareDx (NASDAQ:CDNA), AnaptysBio (NASDAQ:ANAB) and Agenus (NASDAQ:AGEN).
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Morgan Stanley on Friday, August 11, 2023. The analyst firm set a price target for 3.00 expecting ORGO to fall to within 12 months (a possible -6.83% downside). 5 analyst firms have reported ratings in the last year.
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $3.22 last updated September 29, 2023 at 9:08 PM UTC.
There is no dividend information for Organogenesis Hldgs.
Organogenesis Hldgs’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Organogenesis Hldgs.
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
Open3.380 | Close3.180 |
Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.020 | 0.050 | 0.0300 | ||||
REV | 115.100M | 117.316M | 2.216M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-11 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Lowers | 5.00 | 3.00 |
2023-08-10 | BTIG | Ryan Zimmerman | Maintains | BuyBuy | Lowers | 10.00 | 4.00 |
2023-06-15 | Morgan Stanley | Drew Ranieri | Initiates Coverage On | Equal-Weight | Announces | - | 5.00 |
2023-05-24 | BTIG | Ryan Zimmerman | Upgrades | NeutralBuy | Announces | - | 10.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ORGO | Organogenesis Hldgs | -5.01% | 422.8M |
RNA | Avidity Biosciences | -3.96% | 466.8M |
FDMT | 4D Molecular Therapeutics | 0.71% | 535.3M |
CDNA | CareDx | -0.57% | 379.2M |
ANAB | AnaptysBio | -0.22% | 476.8M |
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Other companies in Organogenesis Hldgs’s space includes: Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), CareDx (NASDAQ:CDNA), AnaptysBio (NASDAQ:ANAB) and Agenus (NASDAQ:AGEN).
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Morgan Stanley on Friday, August 11, 2023. The analyst firm set a price target for 3.00 expecting ORGO to fall to within 12 months (a possible -6.83% downside). 5 analyst firms have reported ratings in the last year.
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $3.22 last updated September 29, 2023 at 9:08 PM UTC.
There is no dividend information for Organogenesis Hldgs.
Organogenesis Hldgs’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Organogenesis Hldgs.
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
Open3.380 | Close3.180 |
Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.020 | 0.050 | 0.0300 | ||||
REV | 115.100M | 117.316M | 2.216M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-11 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Lowers | 5.00 | 3.00 |
2023-08-10 | BTIG | Ryan Zimmerman | Maintains | BuyBuy | Lowers | 10.00 | 4.00 |
2023-06-15 | Morgan Stanley | Drew Ranieri | Initiates Coverage On | Equal-Weight | Announces | - | 5.00 |
2023-05-24 | BTIG | Ryan Zimmerman | Upgrades | NeutralBuy | Announces | - | 10.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ORGO | Organogenesis Hldgs | -5.01% | 422.8M |
RNA | Avidity Biosciences | -3.96% | 466.8M |
FDMT | 4D Molecular Therapeutics | 0.71% | 535.3M |
CDNA | CareDx | -0.57% | 379.2M |
ANAB | AnaptysBio | -0.22% | 476.8M |
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Other companies in Organogenesis Hldgs’s space includes: Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), CareDx (NASDAQ:CDNA), AnaptysBio (NASDAQ:ANAB) and Agenus (NASDAQ:AGEN).
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Morgan Stanley on Friday, August 11, 2023. The analyst firm set a price target for 3.00 expecting ORGO to fall to within 12 months (a possible -6.83% downside). 5 analyst firms have reported ratings in the last year.
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $3.22 last updated September 29, 2023 at 9:08 PM UTC.
There is no dividend information for Organogenesis Hldgs.
Organogenesis Hldgs’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Organogenesis Hldgs.
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
Open3.380 | Close3.180 |
Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.020 | 0.050 | 0.0300 | ||||
REV | 115.100M | 117.316M | 2.216M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-11 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Lowers | 5.00 | 3.00 |
2023-08-10 | BTIG | Ryan Zimmerman | Maintains | BuyBuy | Lowers | 10.00 | 4.00 |
2023-06-15 | Morgan Stanley | Drew Ranieri | Initiates Coverage On | Equal-Weight | Announces | - | 5.00 |
2023-05-24 | BTIG | Ryan Zimmerman | Upgrades | NeutralBuy | Announces | - | 10.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ORGO | Organogenesis Hldgs | -5.01% | 422.8M |
RNA | Avidity Biosciences | -3.96% | 466.8M |
FDMT | 4D Molecular Therapeutics | 0.71% | 535.3M |
CDNA | CareDx | -0.57% | 379.2M |
ANAB | AnaptysBio | -0.22% | 476.8M |
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Other companies in Organogenesis Hldgs’s space includes: Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), CareDx (NASDAQ:CDNA), AnaptysBio (NASDAQ:ANAB) and Agenus (NASDAQ:AGEN).
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Morgan Stanley on Friday, August 11, 2023. The analyst firm set a price target for 3.00 expecting ORGO to fall to within 12 months (a possible -6.83% downside). 5 analyst firms have reported ratings in the last year.
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $3.22 last updated September 29, 2023 at 9:08 PM UTC.
There is no dividend information for Organogenesis Hldgs.
Organogenesis Hldgs’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Organogenesis Hldgs.
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
Open3.380 | Close3.180 |
Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.020 | 0.050 | 0.0300 | ||||
REV | 115.100M | 117.316M | 2.216M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-11 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Lowers | 5.00 | 3.00 |
2023-08-10 | BTIG | Ryan Zimmerman | Maintains | BuyBuy | Lowers | 10.00 | 4.00 |
2023-06-15 | Morgan Stanley | Drew Ranieri | Initiates Coverage On | Equal-Weight | Announces | - | 5.00 |
2023-05-24 | BTIG | Ryan Zimmerman | Upgrades | NeutralBuy | Announces | - | 10.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ORGO | Organogenesis Hldgs | -5.01% | 422.8M |
RNA | Avidity Biosciences | -3.96% | 466.8M |
FDMT | 4D Molecular Therapeutics | 0.71% | 535.3M |
CDNA | CareDx | -0.57% | 379.2M |
ANAB | AnaptysBio | -0.22% | 476.8M |
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Other companies in Organogenesis Hldgs’s space includes: Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), CareDx (NASDAQ:CDNA), AnaptysBio (NASDAQ:ANAB) and Agenus (NASDAQ:AGEN).
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Morgan Stanley on Friday, August 11, 2023. The analyst firm set a price target for 3.00 expecting ORGO to fall to within 12 months (a possible -6.83% downside). 5 analyst firms have reported ratings in the last year.
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $3.22 last updated September 29, 2023 at 9:08 PM UTC.
There is no dividend information for Organogenesis Hldgs.
Organogenesis Hldgs’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Organogenesis Hldgs.
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.